Chih-Wei Lin

Title: Innovations in Cancer Treatment by Chih-Wei Lin

Introduction

Chih-Wei Lin is a prominent inventor based in Keelung, Taiwan. He has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical compositions for cancer treatment and detection. With a total of 3 patents, Lin's work is paving the way for innovative therapies in oncology.

Latest Patents

Lin's latest patents focus on compositions and methods for the treatment and detection of cancers. One of his notable inventions includes a pharmaceutical composition comprising antibodies or antigen binding fragments that bind to globo H, SSEA3, and SSEA-4. These compositions are designed for use in cancer therapies and diagnostics. The antibodies can target specific cancer cell surfaces, including those found in various carcinomas such as brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and prostate cancers. Another patent emphasizes a similar pharmaceutical composition that specifically binds to SSEA-4, further enhancing the potential for targeted cancer therapies.

Career Highlights

Chih-Wei Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading experts in the field, contributing to groundbreaking research in cancer treatment.

Collaborations

Lin has worked alongside notable colleagues such as Chi-Huey Wong and Tsui-Ling Hsu. Their collaborative efforts have been instrumental in advancing the research and development of innovative cancer therapies.

Conclusion

Chih-Wei Lin's contributions to cancer research through his patents and collaborations highlight the importance of innovation in medical science. His work continues to inspire advancements in cancer treatment and diagnostics, making a significant impact in the field.